Philipp Lohneis

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Epidermal Growth Factor Receptor

Diffuse Large B Cell Lymphoma

Top Venues

Nature communications

Blood cancer discovery

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruth Flumann, Julia Hansen, Benedikt W Pelzer, Pascal Nieper, Tim Lohmann, Ilmars Kisis, Tobias Riet, Viktoria Kohlhas, Phuong-Hien Nguyen, Martin Peifer, Nima Abedpour, Graziella Bosco, Roman K Thomas, Moritz Kochanek, Jacqueline Knufer, Lorenz Jonigkeit, Filippo Beleggia, Alessandra M E Holzem, Reinhard Buttner, Philipp Lohneis, Jorn Meinel, Monika Ortmann, Thorsten Persigehl, Michael Hallek, Dinis Pedro Calado, Markus Chmielewski, Sebastian Klein, Joachim R Göthert, Bjoern Chapuy, Elena I Rugarli, Frank Thomas Wunderlich, Bastian von Tresckow, Ron D Jachimowicz, Ari M Melnick, Hans Christian Reinhardt, Gero Knittel
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood cancer discovery (2022)
Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D'Rozario, Emily S Thomas, Qi-Xiang Li, Clemens A Schmitt, Julie George, Roman K Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Buttner, Roland T Ullrich, Jens Thomas Siveke, Kadoaki Ohashi, Martin Schlee, Martin L Sos
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nature communications 12 (1) (2021)
Philipp Lohneis, Lena Hieggelke, Florian Gebauer, Markus Ball, Christiane Bruns, Reinhard Büttner, Heike Löser, Alexander Quaas
Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma. Virchows Archiv : an international journal of pathology 478 (3) (2020)